Omega, eyeing new uses for genome-tuning tech, taps Stanford to find ocular disease targets
Omega, eyeing new uses for genome-tuning tech, taps Stanford to [...]
Omega, eyeing new uses for genome-tuning tech, taps Stanford to [...]
OnKure sets Diamond in C-suite ahead of Pfizer drug combo [...]
After 15 years helping lead early cancer research at Genentech, [...]
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in [...]
Aum bags $27M to hit cancer targets pursued by Bayer, [...]
Apnimed sees positives in midstage data for its attempt at [...]
J&J science chief Stoffels to retire after decade at the [...]
Boston biotech backers quit Dana-Farber board after U-turn on investment [...]
CureVac giving up on first COVID mRNA vax, focusing on [...]
Brain atlas unveils dozens of cell types that control movement [...]